- Home
- A-Z Publications
- Current Drug Metabolism
- Previous Issues
- Volume 12, Issue 9, 2011
Current Drug Metabolism - Volume 12, Issue 9, 2011
Volume 12, Issue 9, 2011
-
-
Editorial [Hot Topic: Multi-Component Drug ADME/T and Metabolic Interactions (Guest Editor: Ping Li)]
By Ping LiWith the ever-increasing acceptance of combination therapy and the prevalence of chronic diseases in the world, the development of multi-component drug therapies including the use of herbs has become an emerging trend. Herbal medicines (HMs), generally prepared with a specific combination of different herbs, are becoming increasingly popular as a multi-component drug therapy. In addition, drug combination, as Read More
-
-
-
Strategies for Integral Metabolism Profile of Multiple Compounds in Herbal Medicines: Pharmacokinetics, Metabolites Characterization and Metabolic Interactions
Authors: Gui-Zhong Xin, Lian-Wen Qi, Zi-Qi Shi, Ping Li, Hai-Ping Hao, Guang-Ji Wang and Jing ShangHerbal medicines (HMs) are gaining more and more attention all over the world, because of their significant curative effect in treating multi-factorial diseases. Recently, the in vivo and in vitro metabolism study of HMs has become an important issue because these data can help us to better understand the efficacies and toxicities of HMs. However, the integral metabolism profile of HMs is confronted with many challen Read More
-
-
-
Metabolism of Ginseng and its Interactions with Drugs
Authors: Lian-Wen Qi, Chong-Zhi Wang, Guang-Jian Du, Zhi-Yu Zhang, Tyler Calway and Chun-Su YuanGinseng is an herbal medicine used worldwide. It is reported to have a wide range of pharmacological activities because of a diversified group of steroidal saponins called ginsenosides. Compared to extensive pharmacological studies of ginseng, the pharmacokinetics, especially the metabolism of this herb, has received less attention. In this article we review the known pharmacokinetic data on ginseng. Understandin Read More
-
-
-
Hepatotoxicity and Tumorigenicity Induced by Metabolic Activation of Pyrrolizidine Alkaloids in Herbs
Authors: Na Li, Qingsu Xia, Jianqing Ruan, Peter P. Fu and Ge LinIn the recent decades, the use of herbal products has been rapidly growing in the Western countries. While their use in many cases causes adverse effects, to date, safety issues of herbal products have not been adequately addressed. It is rarely determined whether the non-purported bioactive constituents in the herbs and the metabolites of the bioactive components can lead to adverse effects. In this review, we discuss, using Read More
-
-
-
Herb-drug Interactions Involving Drug Metabolizing Enzymes and Transporters
Authors: Chang-Xiao Liu, Xiu-Lin Yi, Duan-Yun Si, Xue-Feng Xiao, Xin He and Ya-Zhuo LiHerbal medicines and their active ingredients are widely used worldwide, and they have become an important part of clinical medicine. The combined use of herbs and drugs has increased the possibility of pharmacokinetic and pharmacodynamic interactions. Clinical studies have demonstrated that the combined use of herbs and drugs can enhance or attenuate the drug efficacy and toxicity. The herb-drug combin Read More
-
-
-
Translational Research Insights into Pharmacokinetic Herb-Drug Interactions
Authors: Haiping Hao, Xiao Zheng, Ping Li and Guangji WangTranslational research is an emerging discipline that aims to fill the gap through the whole pipeline from bench to bedside. This review highlights the importance and urgency of incorporating translational research into the study of pharmacokinetic herb drug interactions (PHDI), based on an intensive discussion on the controversial and inconsistent reports from preclinical to clinical, in vitro to in vivo, and across different studi Read More
-
-
-
Prediction of Drug-Drug Interactions Arising From Mechanism-Based Inactivation: Key Input Parameters and Impact on Risk Assessment
More LessAs the prevalence of polypharmacy increases with our aging population, the propensity for adverse drug-drug interactions arising from the altered metabolism of co-administered medicines remains an important consideration for drug development. Mechanismbased inactivation (MBI) of the cytochrome P450 enzyme system is responsible for many clinically relevant drug-drug interactions (DDIs) due to the irreversible and lon Read More
-
-
-
Dual Function of Nitric Oxide in Carcinogenesis, Reappraisal
More LessNitric oxide, a unique signalling molecule, is synthesized from L-arginine by a family of isoenzymes called nitric oxide synthase. Function of nitric oxide largely depends on the concentrations of surrounding free radicals and redox state. The local concentration of the nitric oxide defines its anti- or protumorigenic function by interacting with DNA or DNA repair enzymes and tumor suppressor gene, p53, as well. Indoleamine 2,3-di Read More
-
-
-
Regioselective Sulfation and Glucuronidation of Phenolics: Insights into the Structural Basis
Authors: Baojian Wu, Sumit Basu, Shengnan Meng, Xiaoqiang Wang and Ming HuThe phase II metabolism sulfation and glucuronidation, mediated by sulfotransferases (SULTs) and UDP-glucuronosyltransferases (UGTs) respectively, are significant metabolic pathways for numerous endo-and xenobiotics. Understanding of SULT/UGT substrate specificity including regioselectivity (i.e., position preference) is of great importance in predicting contribution of sulfation/ glucuronidation to drug and meta Read More
-
Volumes & issues
-
Volume 25 (2024)
-
Volume 24 (2023)
-
Volume 23 (2022)
-
Volume 22 (2021)
-
Volume 21 (2020)
-
Volume 20 (2019)
-
Volume 19 (2018)
-
Volume 18 (2017)
-
Volume 17 (2016)
-
Volume 16 (2015)
-
Volume 15 (2014)
-
Volume 14 (2013)
-
Volume 13 (2012)
-
Volume 12 (2011)
-
Volume 11 (2010)
-
Volume 10 (2009)
-
Volume 9 (2008)
-
Volume 8 (2007)
-
Volume 7 (2006)
-
Volume 6 (2005)
-
Volume 5 (2004)
-
Volume 4 (2003)
-
Volume 3 (2002)
-
Volume 2 (2001)
-
Volume 1 (2000)
Most Read This Month
Article
content/journals/cdm
Journal
10
5
false
en
